- Home
- PLSE vs OCUL Comparison
PLSE vs OCUL Comparison
Compare PLSE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | OCUL |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PLSE | OCUL |
|---|---|---|
| Price | $24.97 | $8.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $22.00 | ★ $23.56 |
| AVG Volume (30 Days) | 338.3K | ★ 2.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $840.00 | $7.93 |
| Revenue Next Year | $287.54 | $96.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $12.56 | $6.23 |
| 52 Week High | $28.53 | $16.44 |
Technical Indicators
Market Signals| Indicator | PLSE | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 50.44 |
| Support Level | $23.60 | $8.36 |
| Resistance Level | $26.30 | $9.93 |
| Average True Range (ATR) | 1.53 | 0.44 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 26.98 | 63.12 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.